Maxwell GL - Search Results

1

The promise of molecular staging for the future.

Maxwell GL, Mutch DG. Maxwell GL, et al. Cancer. 2017 Mar 1;123(5):728-730. doi: 10.1002/cncr.30504. Epub 2017 Jan 6. Cancer. 2017. PMID: 28061001 Free article. No abstract available.

2

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.

Maxwell GL, Risinger JI, Gumbs C, Shaw H, Bentley RC, Barrett JC, Berchuck A, Futreal PA. Maxwell GL, et al. Cancer Res. 1998 Jun 15;58(12):2500-3. Cancer Res. 1998. PMID: 9635567

3

Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.

Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, Berchuck A. Maxwell GL, et al. Clin Cancer Res. 2000 Aug;6(8):2999-3005. Clin Cancer Res. 2000. PMID: 10955777

4

Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Maxwell GL, Tian C, Risinger J, Brown CL, Rose GS, Thigpen JT, Fleming GF, Gallion HH, Brewster WR; Gynecologic Oncology Group study. Maxwell GL, et al. Cancer. 2006 Nov 1;107(9):2197-205. doi: 10.1002/cncr.22232. Cancer. 2006. PMID: 17001661 Free article.

5

Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?

Maxwell GL, Tian C, Risinger JI, Hamilton CA, Barakat RR; Gynecologic Oncology Group Study. Maxwell GL, et al. Cancer. 2008 Sep 15;113(6):1431-7. doi: 10.1002/cncr.23717. Cancer. 2008. PMID: 18698590 Free PMC article.

6

Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes.

Teng PN, Wang G, Hood BL, Conrads KA, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Teng PN, et al. Among authors: maxwell gl. Br J Cancer. 2014 Jan 7;110(1):123-32. doi: 10.1038/bjc.2013.687. Epub 2013 Oct 31. Br J Cancer. 2014. PMID: 24178762 Free PMC article.

7

Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.

Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP. Marcus CS, et al. Among authors: maxwell gl. J Cancer. 2014 Jan 1;5(1):25-30. doi: 10.7150/jca.7810. J Cancer. 2014. PMID: 24396495 Free PMC article. Review.

8

Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGFβ pathway.

Bokhari AA, Lee LR, Raboteau D, Hamilton CA, Maxwell GL, Rodriguez GC, Syed V. Bokhari AA, et al. Among authors: maxwell gl. Cancer Prev Res (Phila). 2014 Oct;7(10):1045-55. doi: 10.1158/1940-6207.CAPR-14-0054. Epub 2014 Jul 28. Cancer Prev Res (Phila). 2014. PMID: 25070663

9

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD. Rungruang BJ, et al. Among authors: maxwell gl. Cancer. 2017 May 15;123(6):985-993. doi: 10.1002/cncr.30414. Epub 2016 Nov 16. Cancer. 2017. PMID: 27864921 Free PMC article.

10

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.

Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, Shriver CD, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL. Bateman NW, et al. Among authors: maxwell gl. Cancer. 2017 Oct 15;123(20):4004-4012. doi: 10.1002/cncr.30813. Epub 2017 Jun 27. Cancer. 2017. PMID: 28654152 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page